<p>The median time to BP control in this study was longer than that recommended by clinical trials and most prior estimates. Combination therapy and the absence of comorbidities shorten the time to BP control, whereas delayed control is associated with advanced age, stage II hypertension, and elevated creatinine and FBS levels. These findings underscore the need for close follow-up and frequent counseling, regular end‒organ evaluation, effective treatment and control of underlying comorbidities and the use of combination therapy to achieve prompt BP control.</p>